News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genetic Variation Of Enzyme Linked With Outcomes For Women Receiving Tamoxifen, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Study



10/7/2009 7:24:12 AM

Bookmark and Share

EurekAlert! -- Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.

Read at EurekAlert!
Read at MedPageToday
Read at ScienceDaily


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES